These results were consistent with serum biochemical analyses (Figure 6); animals partially but significantly prevented enzymatic increases in the hepatocellular necrosis marker (ALT) and the cholestasis marker (ALP or GGT). The gene discussed is GPT; the disease is cholestasis.